Maiara Correa De Moraes

Dr. Maiara Correa De Moraes


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MMMaiara Correa De Moraes
Maiara Correa De Moraes
RFRafaele Frassini
Rafaele Frassini
MRMariana Roesch-Ely
Mariana Roesch-Ely
FPFávero Reisdorfer Paula
Fávero Reisdorfer Paula
Thiago BarcellosThiago Barcellos
Thiago Barcellos
A new series of compounds planned by molecular hybridization of the nucleobases uracil and thymine, or the xanthine theobromine, with coumarins, and linked through 1,2,3-triazole heterocycles were evaluated for their in vitro anticancer activity against the human tumor cell lines: colon carcinoma (HCT116), laryngeal tumor cells (Hep-2), and lung carcinoma cells (A549). The hybrid compound 9a exhibited better activity in the series, showing an IC50 of 24.19 ± 1.39 μM against the HCT116 cells, with a selectivity index (SI) of 6, when compared to the cytotoxicity against the non-tumor cell line HaCat. The in silico search for pharmacological targets was achieved through molecular docking studies on all active compounds, which suggested that the synthesized compounds possess a high affinity to the Topoisomerase 1–DNA complex, supporting their antitumor activity. The in silico toxicity prediction studies suggest that the compounds present a low risk of causing theoretical mutagenic and tumorigenic effects. These findings indicate that molecular hybridization from natural derivative molecules is an interesting approach to seek new antitumor candidates.

23 May 2023 in ChemRxiv
Verified
Preprint
Open access
PDF file
MMMaiara Correa De Moraes
Maiara Correa De Moraes
RFRafaele Frassini
Rafaele Frassini
MRMariana Roesch-Ely
Mariana Roesch-Ely
FPFávero Reisdorfer Paula
Fávero Reisdorfer Paula
Thiago BarcellosThiago Barcellos
Thiago Barcellos
A new series of compounds planned by molecular hybridization of the nucleobases uracil and thymine, or the xanthine theobromine, with coumarins, and linked through 1,2,3-triazole heterocycles were evaluated for their in vitro anticancer activity against the human tumor cell lines: colon carcinoma (HCT116), laryngeal tumor cells (Hep-2), and lung carcinoma cells (A549). The hybrid compound 7a exhibited better activity in the series, showing an IC50 of 24.19 ± 1.39 μM against the HCT116 cells, with a selectivity index (SI) of 6, when compared to the cytotoxicity against the non-tumor cell line HaCat. Molecular docking studies were performed on all active compounds and suggested that the synthesized compounds possess a high affinity to DNA Topoisomerase-1 protein, supporting their antitumor activity. The in silico toxicity prediction studies suggest that the compounds present a low risk of causing theoretical mutagenic and tumorigenic effects. These findings indicate that the molecular hybridization from natural derivative molecules is an interesting approach to seek new antitumor candidates.